Sun Biomedical Limited (SBN, Harrington Group Limited) is
involved in the commercialisation of Sun Biomedical
Laboratories Inc drug testing portfolio of products with a
specific focus on their unique proprietary oral-fluid based
drug testing device, OraLine.